Year |
Citation |
Score |
2014 |
Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 765-71. PMID 24627436 DOI: 10.2967/Jnumed.113.124057 |
0.579 |
|
2010 |
Barrett JA, Joyal JL, Hillier SM, Maresca KP, Femia FJ, Kronauge JF, Boyd M, Mairs RJ, Babich JW. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution. Cancer Biotherapy & Radiopharmaceuticals. 25: 299-308. PMID 20578835 DOI: 10.1089/Cbr.2009.0695 |
0.611 |
|
2010 |
Maresca KP, Marquis JC, Hillier SM, Lu G, Femia FJ, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide. Bioconjugate Chemistry. 21: 1032-42. PMID 20402463 DOI: 10.1021/Bc900517X |
0.628 |
|
2009 |
Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Research. 69: 6932-40. PMID 19706750 DOI: 10.1158/0008-5472.Can-09-1682 |
0.607 |
|
2009 |
Maresca KP, Hillier SM, Femia FJ, Zimmerman CN, Levadala MK, Banerjee SR, Hicks J, Sundararajan C, Valliant J, Zubieta J, Eckelman WC, Joyal JL, Babich JW. Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC). Bioconjugate Chemistry. 20: 1625-33. PMID 19572702 DOI: 10.1021/Bc900192B |
0.676 |
|
2009 |
Maresca KP, Hillier SM, Femia FJ, Keith D, Barone C, Joyal JL, Zimmerman CN, Kozikowski AP, Barrett JA, Eckelman WC, Babich JW. A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer. Journal of Medicinal Chemistry. 52: 347-57. PMID 19111054 DOI: 10.1021/Jm800994J |
0.635 |
|
2008 |
Femia FJ, Maresca KP, Hillier SM, Zimmerman CN, Joyal JL, Barrett JA, Aras O, Dilsizian V, Eckelman WC, Babich JW. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 970-7. PMID 18483087 DOI: 10.2967/Jnumed.107.049064 |
0.627 |
|
2008 |
Urbanczyk-Pearson LM, Femia FJ, Smith J, Parigi G, Duimstra JA, Eckermann AL, Luchinat C, Meade TJ. Mechanistic investigation of beta-galactosidase-activated MR contrast agents. Inorganic Chemistry. 47: 56-68. PMID 18072754 DOI: 10.1021/Ic700888W |
0.319 |
|
2002 |
Maresca KP, Shoup TM, Femia FJ, Burker MA, Fischman A, Babich JW, Zubieta J. Synthesis, characterization, and biodistribution of a Technetium-99m ‘3+1’ fatty acid derivative. The crystal and molecular structures of a series of oxorhenium model complexes Inorganica Chimica Acta. 338: 149-156. DOI: 10.1016/S0020-1693(02)01015-0 |
0.708 |
|
2001 |
Chen X, Femia FJ, Babich JW, Zubieta J. Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N). Inorganica Chimica Acta. 315: 147-152. PMID 21603092 DOI: 10.1016/S0020-1693(01)00302-4 |
0.536 |
|
2001 |
Chen X, Femia FJ, Babich JW, Zubieta J. Schiff base chemistry of the rhenium(V)-oxo core with '3+2' ligand donor sets. Inorganica Chimica Acta. 316: 33-40. PMID 20628543 DOI: 10.1016/S0020-1693(01)00387-5 |
0.606 |
|
2001 |
Chen X, Femia FJ, Babich JW, Zubieta J. Synthesis, characterization and crystal structures of mono-, di- and trinuclear rhenium(I) tricarbonyl complexes with 2,3,5,6-tetra(2-pyridyl)pyrazine. Inorganica Chimica Acta. 315: 66-72. PMID 20628541 DOI: 10.1016/S0020-1693(01)00335-8 |
0.574 |
|
2001 |
Chen X, Femia FJ, Babich JW, Zubieta JA. Rhenium(I) carbonyl complexes of 2,4,6-tris(2-pyridyl)-1,3,5-triazine (TPT). Rhenium(I)-promoted methoxylation of the triazine ring carbon atom in dinuclear rhenium complexes. Inorganic Chemistry. 40: 2769-77. PMID 11375694 DOI: 10.1021/Ic000446G |
0.523 |
|
2001 |
Babich JW, Graham W, Femia FJ, Dong Q, Barzana M, Ferrill K, Fischman AJ, Zubieta J. 6-Mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m Inorganica Chimica Acta. 323: 23-36. DOI: 10.1016/S0020-1693(01)00600-4 |
0.533 |
|
2001 |
Femia FJ, Chen X, Babich JW, Zubieta J. Synthesis and characterization of a ‘3+2’ {Re(V)O}3+ core complex carrying the ONS/PO donor atom set Inorganica Chimica Acta. 316: 145-148. DOI: 10.1016/S0020-1693(01)00394-2 |
0.59 |
|
2001 |
Chen X, Femia FJ, Babich JW, Zubieta J. Spectroscopic and structural studies of complexes of the fac-[Re(N∩N)(CO)3L]n+ type (N∩N=2-(2-pyridyl)benzothiazole; L=Cl, Br, CF3SO3 −, CH3CN) Inorganica Chimica Acta. 314: 91-96. DOI: 10.1016/S0020-1693(01)00301-2 |
0.524 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. Investigations of the {ReO} core: A '2+2' complex from bidentate and potentially trident ligands: [ReO(η-HOC(6)H(4)-2-CH(2)NC(6)H(4)S)(η-SC(5)H(4)N)(PPh(3))]. Inorganica Chimica Acta. 306: 38-41. PMID 21625343 DOI: 10.1016/S0020-1693(00)00146-8 |
0.634 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. An unexpected '4+2' [N(3)S]:[NS] rhenium(IV) complex formed upon cleavage of a Re(V) imido bond. Inorganica Chimica Acta. 310: 237-241. PMID 20703331 DOI: 10.1016/S0020-1693(00)00278-4 |
0.622 |
|
2000 |
Femia FJ, Chen X, Maresca KP, Babich JW, Zubieta J. Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands. Inorganica Chimica Acta. 310: 210-216. PMID 20640229 DOI: 10.1016/S0020-1693(00)00287-5 |
0.716 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubita J. Structural characterizations of an Re(IV) complex [ReCl(4)(OPPh(3))(2)] and of an imino species [ReOCl(2)(PPh(3))(eta-OC(6)H(4)-2-CH=NH)] prepared from the reaction of [ReOCl(3)(PPh(3))(2)] with salicylaldoxime. Inorganica Chimica Acta. 306: 112-115. PMID 20628542 DOI: 10.1016/S0020-1693(00)00145-6 |
0.484 |
|
2000 |
Femia FJ, Chen X, Maresca KP, Shoup TM, Babich JW, Zubieta J. Synthesis and characterization of complexes of the {ReO} core with SNS and S donor ligands. Inorganica Chimica Acta. 306: 30-37. PMID 20628539 DOI: 10.1016/S0020-1693(00)00144-4 |
0.739 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))]. Inorganica Chimica Acta. 307: 149-153. PMID 20617115 DOI: 10.1016/S0020-1693(00)00191-2 |
0.629 |
|
2000 |
Femia FJ, Chen X, Maresca KP, Babich JW, Zubieta J. Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4). Inorganica Chimica Acta. 307: 160-163. PMID 20613968 DOI: 10.1016/S0020-1693(00)00207-3 |
0.706 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization. Inorganica Chimica Acta. 307: 154-159. PMID 20592952 DOI: 10.1016/S0020-1693(00)00193-6 |
0.638 |
|
2000 |
Femia FJ, Chen X, Babich JW, Zubieta J. Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands. Inorganica Chimica Acta. 300: 517-524. PMID 20592940 DOI: 10.1016/S0020-1693(99)00586-1 |
0.594 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand. Inorganica Chimica Acta. 308: 80-90. PMID 20592939 DOI: 10.1016/S0020-1693(00)00218-8 |
0.624 |
|
2000 |
Chen X, Femia FJ, Babich JW, Zubieta J. Synthesis and characterization of oxorhenium(V)-'3+1' mixed thiolate [SNS]/[S] and [ONS]/[S] complexes. Crystal and molecular structures of [ReO(eta-SCH(2)C(5)H(3)NCH(2)S)(eta-C(6)H(4)Br-4-S)], [ReO(eta-SCH(2)C(5)H(3)NCH(2)O)(eta-C(6)H(4)X-4-S)] (X=Cl, OMe), [ReO(eta-SCH(2)C(5)H(3)NCH(2)O)(eta-C(6)H(4)OCH(3)-4-CH(2)S)] and [ReO(eta-SCH(2)C(5)H(3)NCH(2)S)(eta-C(5)H(4)NH-2-S)][Cl]. Inorganica Chimica Acta. 307: 88-96. PMID 20592938 DOI: 10.1016/S0020-1693(00)00209-7 |
0.583 |
|
2000 |
Femia FJ, Babich JW, Zubieta JA. Structural systematics of the {ReO}3+ core with ‘3+2’ ligand donor sets Inorganica Chimica Acta. 300: 462-470. DOI: 10.1016/S0020-1693(99)00539-3 |
0.558 |
|
2000 |
Maresca KP, Femia FJ, Bonavia GH, Babich JW, Zubieta J. Cationic complexes of the ‘3+1’ oxorhenium–thiolate family Inorganica Chimica Acta. 297: 98-105. DOI: 10.1016/S0020-1693(99)00290-X |
0.744 |
|
2000 |
Babich JW, Coco WG, Barrow S, Fischman AJ, Femia FJ, Zubieta JA. 99mTc-labeled chemotactic peptides: influence of coligand on distribution of molecular species and infection imaging properties. Synthesis and structural characterization of model complexes with the {Re(η2-HNNC5H4N)(η1-NNC5H4N)} core Inorganica Chimica Acta. 309: 123-136. DOI: 10.1016/S0020-1693(00)00255-3 |
0.561 |
|
1998 |
Maresca KP, Femia FJ, Babich JW, Zubieta J. Expansion of the ‘3 + 1’ concept of oxorhenium-thiolate chemistry to cationic and binuclear complexes Inorganic Chemistry Communications. 1: 209-212. DOI: 10.1016/S1387-7003(98)00056-2 |
0.706 |
|
Show low-probability matches. |